The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KarMMa-RW: A study of real-world treatment patterns in heavily pretreated patients with relapsed and refractory multiple myeloma (RRMM) and comparison of outcomes to KarMMa.
 
Sundar Jagannath
Honoraria - Celgene; Karyopharm Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Novartis
Research Funding - Bristol-Myers Squibb (Inst); celgene (Inst); Karyopharm Therapeutics (Inst)
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Juno Therapeutics (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)
 
Hartmut Goldschmidt
Honoraria - Art tempi; Bristol-Myers Squibb; Celgene; Chugai Pharma; Janssen-Cilag; Novartis; Sanofi
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Chugai Pharma Europe (Inst); Janssen (Inst); Molecular Partners (Inst); MSD (Inst); Mundipharma (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Novartis; Sanofi; Takeda
 
Donna Ellen Reece
Honoraria - Amgen; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Janssen; Merck; Otsuka; Takeda
Expert Testimony - Amgen; Celgene
 
Ajay K. Nooka
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Spectrum Pharmaceuticals; Takeda
Research Funding - Amgen (Inst); Janssen Oncology (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Paula Rodríguez Otero
Consulting or Advisory Role - Abbvie; Celgene; Janssen; Kite, a Gilead company; Sanofi
Speakers' Bureau - Amgen; Celgene; Janssen
Travel, Accommodations, Expenses - Celgene
 
Kosei Matsue
Honoraria - Celgene; Janssen; Takeda
 
Nina Shah
Stock and Other Ownership Interests - Indapta Therapeutics
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech/Abbvie; Indapta Therapeutics; Karyopharm Therapeutics; Nektar; Nkarta; Oncopeptides; Precision Biosciences; Sanofi; Seagen; Surface Oncology; TeneoBio
Research Funding - Bluebird Bio; Celgene; Janssen; Sutter Medical Group
 
Larry D. Anderson, Jr
Honoraria - Amgen; celgene; GlaxoSmithKline; janssen; takeda
Consulting or Advisory Role - amgen; Bristol-Myers Squibb; celgene; GlaxoSmithKline; janssen
Speakers' Bureau - amgen; celgene; Takeda
Research Funding - amgen; Bristol-Myers Squibb; celgene; janssen
 
Kimberly Wilson
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Arlene S. Swern
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Faiza Zafar
Employment - Bristol-Myers Squibb
Leadership - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Other Relationship - Bristol-Myers Squibb
 
Amit Balkrishna Agarwal
Employment - Bristol-Myers Squibb; Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
David Samuel DiCapua Siegel
Stock and Other Ownership Interests - Celularity
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Karyopharm Therapeutics; Merck; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Takeda
Research Funding - Celgene (Inst)